Gritstone Oncology, Inc. (22)
Browse by Contract Category
Contracts
-
Securities Purchase Agreement, dated October 24, 2022
(Filed With SEC on October 25, 2022)
-
Fourth Amendment to the License Agreement between Gritstone bio, Inc. and MIL 21E, LLC, effective as of June 30, 2022
(Filed With SEC on August 4, 2022)
-
Third Amendment to Research Collaboration and License Agreement, by and between Gritstone Oncology, Inc. and bluebird bio, Inc., effective February 18, 2021
(Filed With SEC on August 5, 2021)
-
Stockholder Agreement, dated January 29, 2021
(Filed With SEC on February 1, 2021)
-
Second Amendment to Office/Laboratory Lease, by and between Gritstone Oncology, Inc. and MIL 21E, LLC, effective as of May 20, 2020
(Filed With SEC on August 5, 2020)
-
Employment Agreement by and between Gritstone Oncology, Inc. and Rahsaan Thompson, effective as of March 2, 2020
(Filed With SEC on May 7, 2020)
-
Lease Termination Agreement, by and between Gritstone Oncology, Inc. and Emery Station Joint Venture, LLC, effective as of January 28, 2019
(Filed With SEC on February 5, 2019)
-
Form of Pre-Funded Warrant
(Filed With SEC on October 25, 2022)
-
Description of Common Stock
(Filed With SEC on March 10, 2022)
-
Securities Purchase Agreement, dated September 16, 2021
(Filed With SEC on September 17, 2021)
-
Stock Purchase Agreement, dated January 29, 2021
(Filed With SEC on February 1, 2021)
-
Securities Purchase Agreement, dated December 28, 2020
(Filed With SEC on December 30, 2020)
-
Securities Purchase Agreement, dated December 22, 2020
(Filed With SEC on December 28, 2020)
-
Form of Pre-Funded Warrant
(Filed With SEC on December 28, 2020)
-
Second Amendment to Research Collaboration and License Agreement, by and between Gritstone Oncology, Inc. and bluebird bio, Inc., effective August 19, 2020
(Filed With SEC on November 5, 2020)
-
Description of Common Stock
(Filed With SEC on March 11, 2020)
-
First Amendment to Office/Laboratory Lease, by and between Gritstone Oncology, Inc. and MIL 21E, LLC, effective as of July 11, 2019
(Filed With SEC on November 12, 2019)
-
Office/Laboratory Lease, by and between Gritstone Oncology, Inc. and MIL 21E, LLC, effective as of September 6, 2018
(Filed With SEC on November 12, 2019)
-
Employment Agreement by and between Gritstone Oncology, Inc. and Vijay Yabannavar, Ph.D., effective as of July 2, 2019
(Filed With SEC on November 12, 2019)
-
Form of Underwriting Agreement
(Filed With SEC on April 22, 2019)
-
Transition and Separation Agreement by and between Gritstone Oncology, Inc. and Jayant Aphale, Ph D., effective as of December 7, 2018
(Filed With SEC on March 28, 2019)
-
Office/Laboratory Lease, by and between Gritstone Oncology, Inc. and Emery Station West, LLC, effective as of January 28, 2019
(Filed With SEC on February 5, 2019)